共 70 条
[1]
Einhorn TA(2014)Bisphosphonate-associated fractures of the femur: pathophysiology and treatment J Orthop Trauma 28 433-8
[2]
Bogdan Y(2011)Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women JAMA 305 783-9
[3]
Tornetta P(2010)Diagnosis of proximal femoral insufficiency fractures in patients receiving bisphosphonate therapy Am J Roentgenol 194 1061-4
[4]
Park-Wyllie LY(2013)Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systemic review and meta-analysis J Bone Miner Res 28 1729-37
[5]
Mamdani MM(1997)Elimination and biochemical response to intravenous alendronate in postmenopausal osteoporosis J Bone Miner Res 12 1700-7
[6]
Juurlink DN(2015)Risk of atypical femoral fracture during and after bisphosphonate use: full report of a nationwide study Acta Orthop 86 100-7
[7]
Porrino JA(2014)Risk of atypical femoral fracture during and after bisphosphonate use N Engl J Med 371 974-6
[8]
Kohl CA(1974)Nonparametric estimation of a survivorship function with doubly censored data J Am Stat 69 169-73
[9]
Taljanovic M(2010)When is a fracture healed? Radiographic and clinical criteria revisited J Orthop Trauma 24 S76-80
[10]
Rogers LF(2008)Variability in assessment of fracture-healing in orthopedic trauma studies J Bone Joint Surg Am 90 1862-8